Correlation Between 159005 and Cabio Biotech

Can any of the company-specific risk be diversified away by investing in both 159005 and Cabio Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 159005 and Cabio Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between 159005 and Cabio Biotech Wuhan, you can compare the effects of market volatilities on 159005 and Cabio Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 159005 with a short position of Cabio Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of 159005 and Cabio Biotech.

Diversification Opportunities for 159005 and Cabio Biotech

0.23

Correlation Coefficient

159005  Cabio Biotech

Modest diversification

The 3 months correlation between 159005 and Cabio is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding 159005 and Cabio Biotech Wuhan in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cabio Biotech Wuhan and 159005 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 159005 are associated (or correlated) with Cabio Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cabio Biotech Wuhan has no effect on the direction of 159005 i.e., 159005 and Cabio Biotech go up and down completely randomly.

Pair Corralation between 159005 and Cabio Biotech

Assuming the 90 days trading horizon 159005 is expected to generate 9.67 times less return on investment than Cabio Biotech. But when comparing it to its historical volatility, 159005 is 193.88 times less risky than Cabio Biotech. It trades about 0.18 of its potential returns per unit of risk. Cabio Biotech Wuhan is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  1,887  in Cabio Biotech Wuhan on October 9, 2024 and sell it today you would lose (59.00) from holding Cabio Biotech Wuhan or give up 3.13% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

159005  vs.  Cabio Biotech Wuhan

159005

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in 159005 are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, 159005 is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Cabio Biotech Wuhan

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cabio Biotech Wuhan has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Cabio Biotech is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with 159005 and Cabio Biotech

The main advantage of trading using opposite 159005 and Cabio Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 159005 position performs unexpectedly, Cabio Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cabio Biotech will offset losses from the drop in Cabio Biotech's long position.

The idea behind 159005 and Cabio Biotech Wuhan pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.